Physician profile
Emily Danielle Hampton
NPI 1518628254
$1,901.13
in general payments reported to CMS, 2019-2025
21 companies · $20.88 in 2025
The $20.88 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $551 · 2023: $928 · 2024: $402 · 2025: $20.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,349.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $461.66 | 2022-2024 | Xifaxan, Trulance, Plenvu |
| Abbvie INC. | $216.49 | 2022-2025 | |
| Janssen Biotech, INC. | $142.90 | 2023-2024 | Stelara |
| Genzyme Corporation | $139.09 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $129.13 | 2023-2024 | Dupixent |
| Merck Sharp & Dohme LLC | $121.57 | 2022-2024 | Dificid |
| Takeda Pharmaceuticals U.S.A., INC. | $119.61 | 2022-2024 | Entyvio |
| Gilead Sciences, INC. | $77.72 | 2023 | Epclusa |
| Daiichi Sankyo INC. | $76.46 | 2022 | |
| Intercept Pharmaceuticals, INC. | $72.82 | 2022-2024 | |
| Ardelyx, INC. | $70.64 | 2023-2024 | Ibsrela |
| Nestle Healthcare Nutrition INC. | $50.61 | 2022 | |
| Ironwood Pharmaceuticals, INC | $42.63 | 2023 | Linzess |
| Qol Medical, LLC | $34.88 | 2023 | Sucraid |
| Lilly USA, LLC | $32.75 | 2023-2024 | Omvoh |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $32.20 | 2024 | Voquezna |
| Vivus LLC | $20.92 | 2023 | Qsymia |
| Aimmune Therapeutics, INC. | $16.42 | 2024 | |
| Braintree Laboratories, INC. | $15.73 | 2022 | |
| Redhill Biopharma INC. | $13.95 | 2023 | Talicia, Aemcolo, Movantik |
| Fresenius Kabi USA, LLC | $12.95 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Hampton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.